General Refractories Co.

Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN.
Blood Weekly; 12/17/2009; 1087 words; ...Graboyes, senior vice president, general counsel of Allos Therapeutics...of patients with relapsed or refractory peripheral T-cell lymphoma...headquartered in Westminster, CO. For additional information...reactions. Drug Interactions: Co-administration of drugs subject...

China Gengsheng Minerals Gets Positive Feedback from Fine Precision Abrasive End Users.
PR Newswire; 12/7/2009; 1129 words; ...including monolithic refractories, industrial ceramics...Gengsheng Refractories Co., Ltd., Zhengzhou Duesail Fracture Proppant Co., Ltd. and Henan Gengsheng...Temperature Materials Co., Ltd. For more information...of our customers; the general ability of the Company...

Research on asthma discussed by J. Gamble and co-researchers.
Respiratory Therapeutics Week; 12/7/2009; 863 words; ...With the advent of new and expensive therapies for severe refractory asthma, targeting the appropriate patients is important...examine the relationship of poor adherence to asthma outcome. General practitioner prescription refill records for the previous...

Research on life sciences reported by D.A. Barbie et al.
Biotech Week; 12/2/2009; 584 words; ...therapies in some cases, KRAS has remained refractory to this approach," researchers in the United...in KRAS mutant tumours, and establish a general approach for the rational identification of co-dependent pathways in cancer." Barbie...

Aegerion Pharmaceuticals Announces Additional Lomitapide (AEGR-733) Phase III Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Safety Profile.
Biotech Week; 12/2/2009; 1550 words; ...severe patients, who are typically refractory to drug treatments, while providing...Pellizzari, Senior Vice President, General Counsel and Secretary (908) 707-2100 Media Contact: Sard Verbinnen & Co. Jim Barron/Lesley Bogdanow/Nick...